Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (61-70 of 242) with videos related to

Pageof 25
Sort By:
The Cochrane Database of Systematic Reviews|October 15, 2013
Thymectomy for non-thymomatous myasthenia gravisGabriel Cea, Michael Benatar, Renato J Verdugo, et al.
Statistical Methods in Medical Research|May 20, 2026
Likelihood-based modeling of covariate-specific time-dependent receiver operating characteristic curvesAinesh Sewak, Vanda Inácio, Joanne Wuu, et al.
BMJ Neurology Open|January 25, 2024
Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trialMichael Benatar, Heinz Wiendl, Richard Nowak, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 25, 2015
Mind the gap: the mismatch between clinical and imaging metrics in ALSEsther Verstraete, Martin R Turner, Julian Grosskreutz, et al.
Annals of Neurology|July 18, 2018
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversionMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Experimental Neurology|January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug developmentAnna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
Neuroepidemiology|October 26, 2012
Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainmentMichael Wittie, Lorene M Nelson, Sharon Usher, et al.
Muscle & Nerve|October 9, 2012
Reply: To PMID 22581550Donald B Sanders, Michael Benatar, Ted M Burns, et al.
Brain : a Journal of Neurology|December 10, 2024
Rethinking phase 2 trials in amyotrophic lateral sclerosisMichael Benatar, Christopher McDermott, Martin R Turner, et al.
Brain : a Journal of Neurology|February 5, 2025
Reply: Overstating harms can have consequencesMichael Benatar, Christopher McDermott, Martin R Turner, et al.
Pageof 25

Showing results (61-70 of 242) with videos related to

Sort By:
Pageof 25
The Cochrane Database of Systematic Reviews|October 15, 2013
Thymectomy for non-thymomatous myasthenia gravisGabriel Cea, Michael Benatar, Renato J Verdugo, et al.
Statistical Methods in Medical Research|May 20, 2026
Likelihood-based modeling of covariate-specific time-dependent receiver operating characteristic curvesAinesh Sewak, Vanda Inácio, Joanne Wuu, et al.
BMJ Neurology Open|January 25, 2024
Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trialMichael Benatar, Heinz Wiendl, Richard Nowak, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 25, 2015
Mind the gap: the mismatch between clinical and imaging metrics in ALSEsther Verstraete, Martin R Turner, Julian Grosskreutz, et al.
Annals of Neurology|July 18, 2018
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversionMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Experimental Neurology|January 17, 2015
How clinical trials of myasthenia gravis can inform pre-clinical drug developmentAnna Rostedt Punga, Henry J Kaminski, David P Richman, et al.
Neuroepidemiology|October 26, 2012
Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainmentMichael Wittie, Lorene M Nelson, Sharon Usher, et al.
Muscle & Nerve|October 9, 2012
Reply: To PMID 22581550Donald B Sanders, Michael Benatar, Ted M Burns, et al.
Brain : a Journal of Neurology|December 10, 2024
Rethinking phase 2 trials in amyotrophic lateral sclerosisMichael Benatar, Christopher McDermott, Martin R Turner, et al.
Brain : a Journal of Neurology|February 5, 2025
Reply: Overstating harms can have consequencesMichael Benatar, Christopher McDermott, Martin R Turner, et al.
Pageof 25